RecruitingNot Applicable

Prediction of Anxiety and Memory State

United States40 participantsStarted 2024-07-23

Plain-language summary

The purpose of this study is to look at how signals in the brain, body, and behavior relate to anxiety and memory function. This project seeks to develop the CAMERA (Context-Aware Multimodal Ecological Research and Assessment) platform, a state-of-the-art open multimodal hardware/software system for measuring human brain-behavior relationships. The R61 portion of the project is designed to develop the CAMERA platform, which will use multimodal, passive sensor data to predict anxiety-memory state in patients undergoing inpatient monitoring with intracranial electrodes for clinical epilepsy, as well as to build CAMERA's passive data framework and active data framework.

Who can participate

Age range18 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients must have known or suspected Temporal Lobe Epilepsy. * Native or proficient in speaking English or Spanish. * Stereoelectroencephalography (sEEG) cases: The implant plan must include hippocampal head, body, and tail electrodes either unilaterally or bilaterally. * 7th grade reading level (minimum level considered literate for adults) Exclusion Criteria: * Hearing impaired (i.e., not corrected with a hearing aid) * Unable to read the newspaper at arm's length with corrective lenses. * Objective intellectual impairment (estimated IQ \< 70) * Any history of Electroconvulsive Therapy or psychosis (except postictal psychosis for patients) * Psychotic disorder (lifetime) * Current Anxiety disorder, Major Depressive Disorder, or Bipolar Disorder * Neurodegenerative diseases, presence of widespread brain lesions, language problems (other than naming difficulty) * Medical conditions that could potentially affect cognitive performance (e.g., human immunodeficiency virus (HIV) infection, cancer with metastatic potential). * Acute renal failure or end-stage renal disease

What they're measuring

Mean absolute error between predicted and actual ecological momentary assessment (EMA) scores

Timeframe: 1-30 days

Percent of subjects demonstrating improvement in the EMANet prediction over time.

Timeframe: 1-30 days

Trial details

NCT IDNCT06551090

SponsorColumbia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-01

Contact for this trial

Brett E Youngerman, MD

516-946-2145 bey2103@cumc.columbia.edu